News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
191 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33091)
2026 (15575)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3357)
June (775)
Day
1 (65)
3 (19)
4 (205)
5 (197)
6 (190)
7 (229)
8 (170)
10 (33)
11 (150)
12 (194)
13 (208)
14 (261)
15 (58)
17 (52)
18 (160)
19 (145)
20 (146)
21 (119)
22 (102)
24 (37)
25 (10)
26 (177)
27 (191)
28 (158)
29 (80)
31 (1)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
Day
1
3
4
5
6
7
8
10
11
12
13
14
15
17
18
19
20
21
22
24
25
26
27
28
29
31
Rare diseases
FDA accepts BridgeBio’s application for potential first limb-girdle muscular dystrophy drug
The FDA’s priority review acceptance of BridgeBio’s BBP-418 is another step toward what William Blair previously dubbed a “diversified commercial portfolio.” It also adds to the rapidly building momentum in muscular dystrophy more broadly.
May 27, 2026
·
3 min read
·
Heather McKenzie
IPO tracker
Kardigan cozies up to public markets to support heart disease drugs
Analysts are cautiously optimistic about an IPO rebound for biopharma.
BioSpace
is keeping track of companies that seek to trade on the public markets this year.
May 27, 2026
·
14 min read
·
Editorial Team
Press Releases
Acurex Biosciences Awarded ASAP Grant to Advance Breakthrough Approach to Parkinson’s Disease
May 27, 2026
·
3 min read
Press Releases
CordenPharma Acquires AmbioPharm to Expand Global Peptide API Capacity
May 27, 2026
·
7 min read
Press Releases
FluoGuide A/S Publishes Interim Report for Q1 2026
May 27, 2026
·
4 min read
Press Releases
Intravacc Secures French CIR Approval to Support Vaccine R&D Partnerships
May 27, 2026
·
3 min read
Press Releases
Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026
May 27, 2026
·
3 min read
Press Releases
argenx to Present at Upcoming June 2026 Investor Conferences
May 27, 2026
·
1 min read
Press Releases
Alfasigma presents first data on filgotinib from the Phase 3 OLINGUITO trial in axial spondyloarthritis at EULAR 2026
May 27, 2026
·
10 min read
Press Releases
Phase 3 ASSURE Interim Data: Majority of People in the Study with ALP 1–1.67×ULN Achieved High and Sustained Composite ALP Normalization at 24 Months with Gilead’s Livdelzi (Seladelpar)
May 27, 2026
·
13 min read
Previous
2 of 20
Next
